Annual report
2914.TEDINET S100QG4E
Period2022-01-01 → 2022-12-31
Filed2023-03-24
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.66T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.32T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.09T | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.18T | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.22T | 2018-01-01 → 2018-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥653.6bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥499.0bn | 2021-01-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥593.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥472.4bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥420.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥465.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥531.5bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥442.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥338.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥310.3bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥348.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥385.7bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥444.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥340.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥312.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥361.6bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥387.4bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥6.55T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.38T | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.55T | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.46T | at 2018-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.93T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.89T | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.60T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.54T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.81T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥538.8bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥357.2bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥282.1bn | at 2018-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥483.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥598.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥519.8bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥540.4bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥461.4bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥101.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥97.5bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥5.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥123.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥383.3bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥306.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥353.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥297.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥333.8bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥62.4bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥249.45 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥190.76 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥174.88 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥195.97 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥215.31 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥249.36 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥190.68 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥174.8 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥195.87 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥215.2 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,994.78 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,583.1 | at 2021-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,421.92 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,501.12 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,468.44 | at 2018-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 54.1% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 46.9% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.9% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.2% | at 2018-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 13.9% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 13.2% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 14.3% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 52,640 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 55,381 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 58,300 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 61,975 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 63,968 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥542.2bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥592.2bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥596.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥660.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥696.3bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥64.6bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥93.8bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥273.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥278.8bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥240.5bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥279.0bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥190.3bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥310.1bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥236.2bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥283.5bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥216.9bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥241.8bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥262.5bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥164.6bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.36T | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥2.49T | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥2.60T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.61T | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.67T | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥994.6bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.14T | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.37T | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.34T | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.39T | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.42T | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.49T | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥193.4bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥238.1bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥159.72 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.23 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.27 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.72 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.89 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥159.66 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥122.18 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.21 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.65 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥91.84 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥188 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥140 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥154 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥154 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥770.57 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥757.1 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥782.73 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥798.18 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥832.87 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 57.9% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.9% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.9% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.7% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,000,000,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,000,000,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 5,819 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 7,154 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 7,366 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 7,464 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 7,457 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 86
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-01-01 → 2022-12-31 | ¥6.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-12-31 | ¥9.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥7.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥40.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥40.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥41.1bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥7.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥52m |
| Pharmaceuticalsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥2.4bn |
| Pharmaceuticalsreportable segment | employees | at 2022-12-31 | 1331 pure |
| Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥82.9bn |
| Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥82.9bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.1bn |
| Processed Foodreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥8.2bn |
| Processed Foodreportable segment | employees | at 2022-12-31 | 4297 pure |
| Processed Foodreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥155.5bn |
| Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥155.5bn |
| Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥3m |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.5bn |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.5bn |
| Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥4.2bn |
| Tobaccoreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥83.8bn |
| Tobaccoreportable segment | employees | at 2022-12-31 | 46163 pure |
| Tobaccoreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.42T |
| Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.42T |
| Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥332m |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥754.0bn |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥754.0bn |
| Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥679.4bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥94.4bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥2.66T |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥2.66T |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥335m |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥768.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥768.7bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥694.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-01-01 → 2021-12-31 | ¥3.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-12-31 | ¥7.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-12-31 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥5.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-12-31 | −¥43.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-12-31 | −¥43.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-12-31 | −¥37.5bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-12-31 | −¥5.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-12-31 | −¥5.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥120m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥120m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥120m |
| Pharmaceuticalsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥6.0bn |
| Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥80.4bn |
| Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥80.4bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥11.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥11.3bn |
| Processed Foodreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥10.7bn |
| Processed Foodreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥147.2bn |
| Processed Foodreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥147.2bn |
| Processed Foodreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥1m |
| Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥4.0bn |
| Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥4.0bn |
| Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥2.9bn |
| Tobaccoreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥81.0bn |
| Tobaccoreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥2.10T |
| Tobaccoreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥2.10T |
| Tobaccoreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥411m |
| Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥639.2bn |
| Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥639.2bn |
| Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥522.4bn |
| —segment total | capex | 2021-01-01 → 2021-12-31 | ¥97.7bn |
| —segment total | revenue | 2021-01-01 → 2021-12-31 | ¥2.32T |
| —segment total | revenue external | 2021-01-01 → 2021-12-31 | ¥2.32T |
| —segment total | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥412m |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥654.3bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥654.3bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥536.7bn |
| Pharmaceuticalsreportable segment | employees | at 2022-12-31 | 732 pure |
| Processed Foodreportable segment | employees | at 2022-12-31 | 23 pure |
| Tobaccoreportable segment | employees | at 2022-12-31 | 4667 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,113
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)丸地肖幸 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石川航史 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)松下陽一 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)カナダにおける喫煙と健康に関する訴訟に対する引当金の認識の要否の判断 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表注記38.「偶発事象」 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)たばこ資金生成単位に配分されたのれんの評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)連結財務諸表注記14.「のれん及び無形資産」 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)丸地肖幸 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)石川航史 | |
| Cpa3 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)松下陽一 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)子会社株式の評価 | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)財務諸表注記（重要な会計上の見積り） | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior4YearDuration | 2215962000000 | JPY |
| Revenue IFRS (5-year summary) | Prior3YearDuration | 2175626000000 | JPY |
| Revenue IFRS (5-year summary) | Prior2YearDuration | 2092561000000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 2324838000000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYearDuration | 2657832000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior4YearDuration | 531486000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior3YearDuration | 465232000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior2YearDuration | 420063000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 472390000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYearDuration | 593450000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior4YearDuration | 387431000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior3YearDuration | 361622000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior2YearDuration | 312029000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YearDuration | 340181000000 | JPY |
| Profit loss IFRS (5-year summary) | CurrentYearDuration | 444174000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior4YearDuration | 385677000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | 348190000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | 310253000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 338490000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | 442716000000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior4YearDuration | 129302000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |